Tissue Therapies
Holding Companies & Conglomerates · Australia · 1-10 Employees
View Company Info for Free
Overview
Headquarters
L 19 179 Turbot St, Brisbane City, Queen...Phone Number
+61 733343900Website
www.tissuetherapies.orgRevenue
<$5 MillionIndustry
About Tissue Therapies
Tissue Therapies Limited is a health biotechnology company specializing in the development and manufacturing of synthetic proteins for wound healing applications. Their primary product, VitroGro ECM, is designed to treat hard-to-heal wounds such as venous leg ulcers and diabetic foot ulcers, aiming to improve patient outcomes and reduce healthcare costs. The company targets markets in Asia, Australia, Canada, Europe, New Zealand, and the United States, where the economic burden of wound care is significant. Tissue Therapies is committed to pharmaceutical innovation and strives to enhance global health through their advanced wound care solutions.Explore more
Tissue Therapies Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Compare Similar Companies to Tissue Therapies
Compare insights from companies similar to Tissue Therapies, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Tissue Therapies Tech Stack
A closer look at the technologies used by Tissue Therapies
Top Holding Companies & Conglomerates Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Top companies in United Kingdom by revenue
Frequently Asked Questions Regarding Tissue Therapies
Sign Up For FreeTo access detailed company insights
Tissue Therapies Limited is a health biotechnology company specializing in the development and manufacturing of synthetic proteins for wound healing applications. Their primary product, VitroGro ECM, is designed to treat hard-to-heal wounds such as venous leg ulcers and diabetic foot ulcers, aiming to improve patient outcomes and reduce healthcare... Read More
